Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia

Takushi Ooga, Hajime Sato, Atsushi Nagashima, Kazunori Sasaki, Masaru Tomita, Tomoyoshi Soga, Yoshiaki Ohashi

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

Metabolomics is an emerging technology that reveals homeostatic imbalances in biological systems. Global determination of metabolite concentrations in body fluid and tissues provides novel anatomical aspects of pathological conditions that cannot be obtained from target-specific measurements. Here, we characterised metabolic imbalance in Watanabe heritable hyperlipidaemic rabbits as a model of hypercholesterolaemia. Using a mass spectrometry-based system, we measured a total of 335 metabolites in plasma and tissues (liver, aorta, cardiac muscle, and brain) from WHHL and healthy control rabbits. From the comparison between two metabolomic profiles, pathophysiological features including glutathione and phosphatidylcholine metabolism indicated the occurrence of oxidative stress in several tissues. Especially for the liver, imbalanced purine catabolism shed light on the transcriptional activation of xanthine oxidase, which is thought to act in absorbing or possibly triggering oxidative stress. We also applied this system to assess the therapeutic effects of simvastatin administration. After the treatment, a portion of the metabolomic features in pathological conditions showed alterations suggesting restoration of metabolism to the healthy condition. These changes were considered to be due to the pleiotropic action of statin, including antioxidant effects, rather than its main inhibitory action on cholesterol biosynthesis.

Original languageEnglish
Pages (from-to)1217-1223
Number of pages7
JournalMolecular BioSystems
Volume7
Issue number4
DOIs
Publication statusPublished - 2011 Apr 1

Fingerprint

Metabolomics
Dyslipidemias
Anatomy
Animal Models
Anatomical Pathological Conditions
Oxidative Stress
Rabbits
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin
Xanthine Oxidase
Liver
Body Fluids
Therapeutic Uses
Hypercholesterolemia
Phosphatidylcholines
Transcriptional Activation
Glutathione
Aorta
Mass Spectrometry
Myocardium

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Biology

Cite this

Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. / Ooga, Takushi; Sato, Hajime; Nagashima, Atsushi; Sasaki, Kazunori; Tomita, Masaru; Soga, Tomoyoshi; Ohashi, Yoshiaki.

In: Molecular BioSystems, Vol. 7, No. 4, 01.04.2011, p. 1217-1223.

Research output: Contribution to journalArticle

Ooga, Takushi ; Sato, Hajime ; Nagashima, Atsushi ; Sasaki, Kazunori ; Tomita, Masaru ; Soga, Tomoyoshi ; Ohashi, Yoshiaki. / Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. In: Molecular BioSystems. 2011 ; Vol. 7, No. 4. pp. 1217-1223.
@article{f7366f3cd73f434085ae231eddcf9157,
title = "Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia",
abstract = "Metabolomics is an emerging technology that reveals homeostatic imbalances in biological systems. Global determination of metabolite concentrations in body fluid and tissues provides novel anatomical aspects of pathological conditions that cannot be obtained from target-specific measurements. Here, we characterised metabolic imbalance in Watanabe heritable hyperlipidaemic rabbits as a model of hypercholesterolaemia. Using a mass spectrometry-based system, we measured a total of 335 metabolites in plasma and tissues (liver, aorta, cardiac muscle, and brain) from WHHL and healthy control rabbits. From the comparison between two metabolomic profiles, pathophysiological features including glutathione and phosphatidylcholine metabolism indicated the occurrence of oxidative stress in several tissues. Especially for the liver, imbalanced purine catabolism shed light on the transcriptional activation of xanthine oxidase, which is thought to act in absorbing or possibly triggering oxidative stress. We also applied this system to assess the therapeutic effects of simvastatin administration. After the treatment, a portion of the metabolomic features in pathological conditions showed alterations suggesting restoration of metabolism to the healthy condition. These changes were considered to be due to the pleiotropic action of statin, including antioxidant effects, rather than its main inhibitory action on cholesterol biosynthesis.",
author = "Takushi Ooga and Hajime Sato and Atsushi Nagashima and Kazunori Sasaki and Masaru Tomita and Tomoyoshi Soga and Yoshiaki Ohashi",
year = "2011",
month = "4",
day = "1",
doi = "10.1039/c0mb00141d",
language = "English",
volume = "7",
pages = "1217--1223",
journal = "Molecular BioSystems",
issn = "1742-206X",
publisher = "Royal Society of Chemistry",
number = "4",

}

TY - JOUR

T1 - Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia

AU - Ooga, Takushi

AU - Sato, Hajime

AU - Nagashima, Atsushi

AU - Sasaki, Kazunori

AU - Tomita, Masaru

AU - Soga, Tomoyoshi

AU - Ohashi, Yoshiaki

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Metabolomics is an emerging technology that reveals homeostatic imbalances in biological systems. Global determination of metabolite concentrations in body fluid and tissues provides novel anatomical aspects of pathological conditions that cannot be obtained from target-specific measurements. Here, we characterised metabolic imbalance in Watanabe heritable hyperlipidaemic rabbits as a model of hypercholesterolaemia. Using a mass spectrometry-based system, we measured a total of 335 metabolites in plasma and tissues (liver, aorta, cardiac muscle, and brain) from WHHL and healthy control rabbits. From the comparison between two metabolomic profiles, pathophysiological features including glutathione and phosphatidylcholine metabolism indicated the occurrence of oxidative stress in several tissues. Especially for the liver, imbalanced purine catabolism shed light on the transcriptional activation of xanthine oxidase, which is thought to act in absorbing or possibly triggering oxidative stress. We also applied this system to assess the therapeutic effects of simvastatin administration. After the treatment, a portion of the metabolomic features in pathological conditions showed alterations suggesting restoration of metabolism to the healthy condition. These changes were considered to be due to the pleiotropic action of statin, including antioxidant effects, rather than its main inhibitory action on cholesterol biosynthesis.

AB - Metabolomics is an emerging technology that reveals homeostatic imbalances in biological systems. Global determination of metabolite concentrations in body fluid and tissues provides novel anatomical aspects of pathological conditions that cannot be obtained from target-specific measurements. Here, we characterised metabolic imbalance in Watanabe heritable hyperlipidaemic rabbits as a model of hypercholesterolaemia. Using a mass spectrometry-based system, we measured a total of 335 metabolites in plasma and tissues (liver, aorta, cardiac muscle, and brain) from WHHL and healthy control rabbits. From the comparison between two metabolomic profiles, pathophysiological features including glutathione and phosphatidylcholine metabolism indicated the occurrence of oxidative stress in several tissues. Especially for the liver, imbalanced purine catabolism shed light on the transcriptional activation of xanthine oxidase, which is thought to act in absorbing or possibly triggering oxidative stress. We also applied this system to assess the therapeutic effects of simvastatin administration. After the treatment, a portion of the metabolomic features in pathological conditions showed alterations suggesting restoration of metabolism to the healthy condition. These changes were considered to be due to the pleiotropic action of statin, including antioxidant effects, rather than its main inhibitory action on cholesterol biosynthesis.

UR - http://www.scopus.com/inward/record.url?scp=79952679120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952679120&partnerID=8YFLogxK

U2 - 10.1039/c0mb00141d

DO - 10.1039/c0mb00141d

M3 - Article

VL - 7

SP - 1217

EP - 1223

JO - Molecular BioSystems

JF - Molecular BioSystems

SN - 1742-206X

IS - 4

ER -